Bioptix, Inc. (:BIOP) are gapping up 13.47% pre-market with a price of $8.48 on the stock.
Successfully tackling the equity markets may involve owning a wide range of stocks. Some investors may prefer growth stocks while others may opt for value stocks. Having a good mix of both types may help build of solid foundation for the portfolio. Investors may choose stocks in a specific industry that is gaining strength. If the industry is on the rise, the portfolio may be more likely to succeed. Finding companies that are considered leaders in their field may also be on the investor checklist. A company that has a large presence may help ease investor worry, especially in a down market climate. Finding the perfect stocks to add to the portfolio may not always be easy, and in fact it may be quite difficult. Investors may have to lay out goals to help keep things on track for both the short-term and the long haul.
The consensus analysts recommendation at this point stands at 3.00 for Bioptix, Inc.. This is based on a 1-5 scale where 1 indicates a Strong Buy and 5 a Strong Sell. Further, analysts have a 12 month target price of $4.00 on company shares. This is according to the analysts polled by Thomson Reuters which have recently published research reports on the firm.
The equity stands -14.91% away from the 52-week high and 344.13% from the 52-week low. The RSI (Relative Strength Index), an indicator that shows price strength by comparing upward and downward close-to-close movements is 83.25.
With the recent move, the stock now boasts a market cap of 49.85and a beta of 2.48.
Onconova Therapeutics, Inc. (NASDAQ:ONTX) is moving higher befor market open as it moved 7.75% pre-bell. With the move the stock is currently valued at $2.80.
At the time of writing, the stock was trading at $2.80. This represents a change from the opening price of 0.00%. In terms of performance, year to date, the stock is 14.48%. The monthly stock performance comes in at 59.42%. For the quarter, shares are performing at 24.33%. Weekly performance analysis shows the equity at 47.65%.
In taking a look at technical levels, shares are trading 58.32% away from the 50 day simple moving average and 24.08% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -27.84% away from it’s 52- week high and 91.78% away from its 52 week low.
As of writing, Onconova Therapeutics, Inc.’s RSI stands at 80.66. In looking at volatility levels, the shares saw weekly volatility of 18.95% and 11.89% over the past month.